Taro Igarashi
Download the ICS Branding Pack
Open Discussion Session 101 Open Discussion ePosters 343 Perioperative Bleeding Risk After MIST for BPH Is Determined by Antithrombotic Therapy Rather Than Procedure Type: A Multicenter Cohort Study
Open Discussion Session 101 Open Discussion ePosters 344 Persistent Storage Dysfunction After MIST for BPH: Evidence of a Pathophysiological Dissociation Between Obstruction and OAB
Open Discussion Session 103 Open Discussion ePosters 479 A Simple Bedside Risk Score Predicting Catheter-Free Outcomes After MIST for BPH: A Multicenter Study With Direct Clinical Applicability
Open Discussion Session 106 Open Discussion ePosters 613 Systematic Review and Meta-Analysis of Artificial Intelligence-Assisted Cystoscopic Diagnosis in Bladder Cancer and IC/BPS: Clinical Performance and Challenges in CIS vs. Hunner Lesion Differentiation
Podium Short Oral Session 21 Overactive Bladder: Pharmacotherapy and Patient Phenotyping 216 Persistence of Vibegron treatment in elderly patients aged 80 years or over with overactive bladder: The impact of anticholinergic burden and polypharmacy
Podium Session 15 Best Basic Science 229 Effects of oral administration of non-selective Trk inhibitor on bladder overactivity in a rat model of prostatic inflammation
Open Discussion Session 35 On Demand Research Methods / Techniques 535 Effects of oral administration of non-selective Trk inhibitor on bladder function and prostatic inflammation in a mouse model of prostate-specific, conditional deletion of E-cadherin
Podium Short Oral Session 11 Therapeutic Mechanisms 161 Effects of oral administration of histamine-H1 receptor antagonist on bladder overactivity and prostatic inflammation in a rat model of non-bacterial prostatitis
Podium Session 19 Best Basic Science 257 Therapeutic effects of intravesical instillation of liposome-conjugated NGF antisense on NGF overexpression in the bladder and bladder overactivity in a rat model of prostatic inflammation
ICS Member